Anti-troponin I antibodies in renal transplant patients

Revista Portuguesa de Cardiologia - Tập 34 - Trang 85-89 - 2015
José Pedro L. Nunes1,2, Susana Sampaio1,3, Ana Cerqueira3, Ziya Kaya4, Nuno Pardal Oliveira2
1Faculdade de Medicina da Universidade do Porto, Portugal
2Department of Cardiology, Hospital São João, Porto, Portugal
3Department of Nephrology, Hospital São João, Porto, Portugal
4University of Heidelberg, Heidelberg, Germany

Tài liệu tham khảo

de Jager, 2009, Cardiovascular and noncardiovascular mortality among patients starting dialysis, JAMA, 302, 1782, 10.1001/jama.2009.1488 Foley, 2010, Clinical epidemiology of cardiovascular disease in chronic kidney disease, J Renal Care, 36, 4, 10.1111/j.1755-6686.2010.00171.x Port, 1993, Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients, JAMA, 270, 1339, 10.1001/jama.1993.03510110079036 Shmilovich, 2007, Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy, Int J Cardiol, 117, 198, 10.1016/j.ijcard.2006.04.077 Leuschner, 2008, Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction, Eur Heart J, 29, 1949, 10.1093/eurheartj/ehn268 Doesch, 2011, Impact of troponin I-autoantibodies in chronic dilated and ischemic cardiomyopathy, Basic Res Cardiol, 106, 25, 10.1007/s00395-010-0126-z Nunes, 2013, Partially reversible cardiomyopathy after renal transplant associated with anti-troponin I antibodies, Cardiology, 126, 173, 10.1159/000353262 Burt, 1989, Reversal of left ventricular dysfunction after renal transplantation, Ann Intern Med, 111, 635, 10.7326/0003-4819-111-8-635 Wali, 2005, Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease, J Am Coll Cardiol, 45, 1051, 10.1016/j.jacc.2004.11.061 Stone, 2013, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol Blum, 2009, The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis, Atherosclerosis, 203, 325, 10.1016/j.atherosclerosis.2008.08.022 Weitz-Schmidt, 2001, Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site, Nat Med, 7, 687, 10.1038/89058 Ghayour-Mobarhan, 2005, Heat shock protein antibody titers are reduced by statin therapy in dyslipidemic subjects: a pilot study, Angiology, 56, 61, 10.1177/000331970505600108